Synapse - Mikhail Roshal

Results (229)

Myeloid/lymphoid neoplasms with eosinophilia/basophilia and ETV6-ABL1 fusion: Cell-of-origin and response to tyrosine kinase inhibition

Research Letter

Yao, J.; Xu, L.; Aypar, U.; Meyerson, H. J.; Londono, D.; Gao, Q.; Baik, J.; Dietz, J.; Benayed, R.; Sigler, A.; more...
Haematologica (2021)

Fulltext@MSK | Save

Rare and novel RUNX1 fusions in myeloid neoplasms: A single-institute experience

Journal Article

Aypar, U.; Yao, J.; Londono, D. M.; Khoobyar, R.; Scalise, A.; Arcila, M. E.; Roshal, M.; Xiao, W.; Zhang, Y.
Genes Chromosomes and Cancer (2021)

Fulltext@MSK | Save

Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemia

Journal Article

Geyer, M. B.; Ritchie, E. K.; Rao, A. V.; Vemuri, S.; Flynn, J.; Hsu, M.; Devlin, S. M.; Roshal, M.; Gao, Q.; Shukla, M.; more...
Haematologica (2021)

Fulltext@MSK | Save

Venetoclax therapy for relapsed and treatment refractory AML: Clinical outcomes and molecular predictors

Meeting Abstract

Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J. L.; King, A. C.; Daniyan, A.; Famulare, C.; Cuello, B. M.; more...
Blood (2020)

Fulltext@MSK | Save

Clinical outcomes of acute myeloid leukemia patients bridged to allogeneic stem cell transplant by venetoclax combination therapy

Meeting Abstract

Stahl, M.; Menghrajani, K.; Derkach, A.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; Barker, J.; more...
Blood (2020)

Fulltext@MSK | Save

Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia

Meeting Abstract

Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
Blood (2020)

Fulltext@MSK | Save

Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy in newly diagnosed multiple myeloma: final results from a clinical and correlative phase 2 study

Meeting Abstract

Landgren, O.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Diamond, B.; Salcedo, M.; more...
Blood (2020)

Fulltext@MSK | Save

Long-term sustained minimal residual disease (MRD) negativity in patients with multiple myeloma treated with continuous lenalidomide maintenance therapy: A clinical and correlative phase 2 study

Meeting Abstract

Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
Blood (2020)

Fulltext@MSK | Save

Molecular genetic analysis with flow cytometry sorting identifies angioimmunoblastic T-cell lymphoma and concomitant de novo myelodysplastic syndrome arising from the same hematopoietic progenitor

Journal Article

Naganuma, K.; Chan, A.; Zhang, Y.; Lewis, N.; Xiao, W.; Roshal, M.; Dogan, A.; Kizaki, M.; Ho, C.; Yabe, M.
Journal of Hematology (2020)

Fulltext@MSK | Save

Spontaneous remission in a patient with acute myeloid leukemia leading to undetectable minimal residual disease

Journal Article

Helbig, D.; Quesada, A. E.; Xiao, W.; Roshal, M.; Tallman, M. S.; Knorr, D. A.
Journal of Hematology (2020)

Fulltext@MSK | Save